Codexis (CDXS) EBIT Growth (1y) (2011 - 2026)
Codexis (CDXS) EBIT Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -24.89% |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 2,150.96% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 80.62% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 8.65% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 145.20% |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Codexis | 135.70 Mn | 70.56 Mn | 13.18 Mn | 60.74% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 60.74% |
| Dec 31, 2025 | 243.84% |
| Sep 30, 2025 | -14.45% |
| Jun 30, 2025 | 43.42% |
| Mar 31, 2025 | -72.33% |
| Dec 31, 2024 | -2,712.46% |
| Sep 30, 2024 | 48.36% |
| Jun 30, 2024 | -80.04% |
| Mar 31, 2024 | 49.77% |
| Dec 31, 2023 | 102.12% |
| Sep 30, 2023 | -201.43% |
| Jun 30, 2023 | -383.94% |
| Mar 31, 2023 | -182.20% |
| Dec 31, 2022 | -27.59% |
| Sep 30, 2022 | -899.70% |
| Jun 30, 2022 | 41.84% |
| Mar 31, 2022 | 8.40% |
| Dec 31, 2021 | -164.65% |
| Sep 30, 2021 | 121.93% |
| Jun 30, 2021 | 26.54% |